Suzhou Novoprotein Scientific Co (SHSE:688137) ROCE % : -0.80% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Suzhou Novoprotein Scientific Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Suzhou Novoprotein Scientific Co's annualized ROCE % for the quarter that ended in Mar. 2024 was -0.80%.

Suzhou Novoprotein Scientific Co ROCE % Historical Data

The historical data trend for Suzhou Novoprotein Scientific Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Novoprotein Scientific Co ROCE % Chart

Suzhou Novoprotein Scientific Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

176.05

63.91

8.13

0.43

Suzhou Novoprotein Scientific Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial											1.89	0.37	0.30	-0.85	-0.80

Suzhou Novoprotein Scientific Co ROCE % Calculation

Suzhou Novoprotein Scientific Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	9.808	/	( ( (2333.478 - 64.02)	+	(2298.915 - 50.122) )	/ 2 )
	=	9.808	/	( (2269.458	+	2248.793)	/ 2 )
	=	9.808	/	2259.1255
	=	0.43 %

Suzhou Novoprotein Scientific Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-18.08	/	( ( (2298.915 - 50.122)	+	(2310.126 - 57.354) )	/ 2 )
	=	-18.08	/	( ( 2248.793	+	2252.772 )	/ 2 )
	=	-18.08	/	2250.7825
	=	-0.80 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Suzhou Novoprotein Scientific Co (SHSE:688137) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Suzhou Novoprotein Scientific Co ROCE % Related Terms

Thank you for viewing the detailed overview of Suzhou Novoprotein Scientific Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Suzhou Novoprotein Scientific Co (SHSE:688137) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Suzhou Novoprotein Scientific Co Ltd (SHSE:688137) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 228, Yunchuang Road, 3rd & 4th Floor, Wujiang Economic and Technological Development Zone, Jiangsu Province, Suzhou, CHN, 215299

Website

http://www.novoprotein.com.cn

Suzhou Novoprotein Scientific Co Ltd is a high-tech enterprise focusing on recombinant protein application solutions. Its main business is the research and development of target and cytokine proteins, recombinant antibodies, enzymes and reagents, Production and sales, and provide related technical services.

Suzhou Novoprotein Scientific Co (SHSE:688137) Headlines

No Headlines